Feb-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Head & Heal has shown notable progress in the New York market, particularly within the Concentrates category. Over the span from November 2025 to February 2026, the brand has improved its ranking from 41st to 21st, indicating a strong upward trend. This movement suggests increasing consumer interest and acceptance of their products in this category. The sales figures reflect this positive trajectory, with a significant increase from $10,445 in November 2025 to $50,658 in February 2026. Despite not being in the top 30 initially, breaking into this group demonstrates their growing presence and competitiveness in the New York market.
In contrast, Head & Heal's performance in the Tincture & Sublingual category in New York has been more stable. The brand maintained a consistent rank of 2nd place from November 2025 through February 2026. However, there was a slight decline in sales from $350,699 in December 2025 to $287,703 in February 2026, suggesting a potential plateau or seasonal fluctuation in demand. This stability in ranking, despite the sales dip, indicates that Head & Heal has a strong foothold in this category, though it might need to explore strategies to reinvigorate sales growth.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Head & Heal consistently holds the second rank from November 2025 through February 2026, demonstrating stable performance amidst a dynamic market. Despite not surpassing Ayrloom, which maintains a stronghold at the top position, Head & Heal's consistent rank suggests a loyal customer base and effective market strategies. The brand faces competition from Mfny (Marijuana Farms New York) and Veterans Choice Creations (VCC), which have fluctuated between the third and fourth ranks. Notably, Veterans Choice Creations (VCC) overtook Mfny in February 2026, indicating a potential shift in consumer preferences that Head & Heal should monitor closely. Overall, Head & Heal's stable ranking amidst these shifts suggests resilience, but the brand must remain vigilant to maintain its position and potentially challenge Ayrloom's dominance in the future.

Notable Products
In February 2026, the top-performing product for Head & Heal was the Max Strength THC Tincture (1000mg THC, 30ml) in the Tincture & Sublingual category, maintaining its number one rank from previous months despite a slight decrease in sales to 1389 units. The CBD/THC/CBN 2:1:2 Sleep Tincture (600mg CBD, 300mg THC, 600mg CBN, 30ml) also held steady at the second position, continuing its consistent ranking since November 2025. The CBD/THC 2:1 Relief Tincture (600mg CBD, 300mg THC, 30ml) remained in third place, showing stable performance across the months. The Hybrid RSO Dablicator (1g) in the Concentrates category climbed to fourth place in January 2026 and retained this position in February, indicating a rising trend in sales. Lastly, the CBG/THC 4:1 Focus Tincture (600mg CBG, 150mg THC, 30ml, 1oz) consistently ranked fifth, maintaining its position from December 2025 onwards.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







